Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2025

Summary of Significant Accounting Policies [Abstract]

Schedule of Estimated Useful Lives

Following are the estimated useful lives of the Group’s property and equipment:

		Estimated Useful Life		Net Residual Value Rate
Leasehold improvements		3 years			5	%
Office equipment & furniture		3 – 5 years			5	%
Motor vehicles		3 – 5 years			5	%

Schedule of Disaggregated Revenue

The following table summarizes disaggregated revenue from contracts with customers by service type:

		For the Years Ended December 31,
		2023				2024				2025				2025
		RMB				RMB				RMB				US$
Revenue from Internet hospital
– Online pharmacy sales and other sales revenue			69,644,697				87,849,203				149,235,145				21,340,342
– Online consultation service and other service revenue			1,364,274				1,190,397				1,477,013				211,210
Subtotal			71,008,971				89,039,600				150,712,158				21,551,552

Revenue from pharmaceuticals supply chain
– Pharmacy retail sales			6,282,249				6,639,199				5,963,663				852,792
– Pharmacy wholesale			227,561,751				246,879,121				243,239,143				34,782,735
Subtotal			233,844,000				253,518,320				249,202,806				35,635,527
Total			304,852,971				342,557,920				399,914,964				57,187,079